Press Releases

New AHSN analysis of how NHS primary care prescribers use medicines optimisation solution FDB OptimiseRx, shows substantial clinical benefits and financial impact around reducing antipsychotic medicines for at risk patients. A return of £1.20 for every £1 invested was calculated from the impact of just three of more than 4,800 prescribing messages.

FDB (First Databank) has signed a deal to supply its Multilex clinical decision support solution to encompass, Health and Social Care Northern Ireland’s transformation initiative, which will introduce a digital integrated care record to Northern Ireland.

Better and FDB (First Databank) are collaborating in the UK, with FDB providing its Multilex clinical decision support solution into the Better Meds electronic prescribing system.

Academic analysis shows primary care prescribers have been preventing adverse drug reactions, harm and hospital admissions through safer prescribing, after using prescribing tech. The company behind the system also reveals that GPs have helped save hundreds of millions of pounds.

GPs and other NHS prescribers may have helped avoid tens of thousands of falls amongst the elderly after using prescribing decision technology FDB OptimiseRx to deliver guidance on avoiding adverse drug side effects, an Academic Health Science Network study suggests.

FDB (First Databank) continues to operate its business and all of its software solutions as normal.

The Multilex drug database includes records for the available COVID-19 vaccines in the UK (including the COVID-19 mRNA vaccine BNT162B2 manufactured by Pfizer- BioNTech) in line with the NHS BSA Dictionary of Medicines and Devices.

FDB (First Databank) is pleased to announce that their latest medicines optimisation solution, FDB AnalyseRx, has been approved to join the G-Cloud 12 framework, joining FDB OptimiseRx on the government’s latest G-Cloud framework.

Norfolk and Waveney Clinical Commissioning Group to support prescribers to improve the quality and safety of prescribing

University of Nottingham team and FDB partner to flag crucial national safety indicators to thousands of primary care professionals through OptimiseRx prescribing software

FDB today announced that it will be exhibiting at Digital Health Rewired 2020 on 4th March at London Olympia

Charles Tuchinda Named Executive Chairman and Bob Katter Promoted to President

FDB has announced that it has completed content development to improve coverage of lymphoedema appliances, specifically around the addition of dm+d lymphoedema items within the FDB Multilex database.

Calls for GP practices to standardise routine drug therapeutic monitoring after disparity revealed in analysis of practice data from FDB’s OptimiseRx

York Teaching Hospital NHS Foundation Trust was shortlisted for a BBH Award - Best Use of Technology (Acute Care).

Darren Nichols, Managing Director at FDB UK, comments on the findings and recommendations from Public Health England’s review into dependence and withdrawal associated with some prescribed medicines